{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:47Z","timestamp":1790375987336,"version":"4.1.0"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005736","name":"Universit\u00e9 Paris Diderot","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005736","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canc\u00e9rop\u00f4le Ile-de-France-INCa"},{"DOI":"10.13039\/501100005897","name":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie et de Pathologie Sexuellement Transmissible","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1111\/bjd.14626","type":"journal-article","created":{"date-parts":[[2016,4,2]],"date-time":"2016-04-02T19:17:30Z","timestamp":1459624650000},"page":"325-333","source":"Crossref","is-referenced-by-count":32,"title":["KIR3DL2 (CD158k) is a potential therapeutic target in primary cutaneous anaplastic large-cell lymphoma"],"prefix":"10.1093","volume":"175","author":[{"given":"M.","family":"Battistella","sequence":"first","affiliation":[{"name":"D\u00e9partement de Pathologie; AP-HP; H\u00f4pital Saint-Louis; Paris 75010 France"},{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U1165; Paris F-75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Janin","sequence":"additional","affiliation":[{"name":"D\u00e9partement de Pathologie; AP-HP; H\u00f4pital Saint-Louis; Paris 75010 France"},{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U1165; Paris F-75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Jean-Louis","sequence":"additional","affiliation":[{"name":"INSERM U976; Centre de Recherche en Dermatologie; Paris 75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Collomb","sequence":"additional","affiliation":[{"name":"Innate Pharma; Marseille F-13276 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leboeuf","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U1165; Paris F-75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sicard","sequence":"additional","affiliation":[{"name":"Innate Pharma; Marseille F-13276 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bonnafous","sequence":"additional","affiliation":[{"name":"Innate Pharma; Marseille F-13276 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dujardin","sequence":"additional","affiliation":[{"name":"Innate Pharma; Marseille F-13276 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ram-Wolff","sequence":"additional","affiliation":[{"name":"INSERM U976; Centre de Recherche en Dermatologie; Paris 75010 France"},{"name":"D\u00e9partement de Dermatologie; AP-HP; H\u00f4pital Saint-Louis; Paris 75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Kadin","sequence":"additional","affiliation":[{"name":"Roger Williams Medical Center; Providence RI U.S.A"},{"name":"Boston University; Boston MA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bensussan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U976; Centre de Recherche en Dermatologie; Paris 75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bagot","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U976; Centre de Recherche en Dermatologie; Paris 75010 France"},{"name":"D\u00e9partement de Dermatologie; AP-HP; H\u00f4pital Saint-Louis; Paris 75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Michel","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris-Diderot; Sorbonne Paris Cit\u00e9; Paris 75010 France"},{"name":"INSERM U976; Centre de Recherche en Dermatologie; Paris 75010 France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,7,13]]},"reference":[{"key":"10.1111\/bjd.14626-BIB0001|bjd14626-cit-0001","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1046\/j.1365-2370.1997.d01-117.x","article-title":"Function and specificity of human natural killer cell receptors","volume":"24","author":"Moretta","year":"1997","journal-title":"Eur J Immunogenet"},{"key":"10.1111\/bjd.14626-BIB0002|bjd14626-cit-0002","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4+ cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0003|bjd14626-cit-0003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of S\u00e9zary cells: relevance for the diagnosis and follow-up of S\u00e9zary syndrome","volume":"122","author":"Poszepczynska-Guign\u00e9","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0004|bjd14626-cit-0004","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2005-10-4239","article-title":"Significance of circulating T-cell clones in S\u00e9zary syndrome","volume":"107","author":"Ortonne","year":"2006","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0005|bjd14626-cit-0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2133.2009.09364.x","article-title":"Absolute CD3+\u00a0CD158k+ lymphocyte count is reliable and more sensitive than cytomorphology to evaluate blood tumour burden in S\u00e9zary syndrome","volume":"162","author":"Bouaziz","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.14626-BIB0006|bjd14626-cit-0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.jid.5701013","article-title":"CD158K\/KIR3DL2 transcript detection in lesional skin of patients with erythroderma is a tool for the diagnosis of S\u00e9zary syndrome","volume":"128","author":"Ortonne","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0007|bjd14626-cit-0007","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2012.01489.x","article-title":"CD158k\/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides","volume":"21","author":"Ortonne","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.14626-BIB0008|bjd14626-cit-0008","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/path.1251","article-title":"Killer cell immunoglobulin-like receptor expression delineates in\u00a0situ S\u00e9zary syndrome lymphocytes","volume":"199","author":"Wechsler","year":"2003","journal-title":"J Pathol"},{"key":"10.1111\/bjd.14626-BIB0009|bjd14626-cit-0009","first-page":"415","volume-title":"Leukocyte Typing VII","author":"Parolini","year":"2002"},{"key":"10.1111\/bjd.14626-BIB0010|bjd14626-cit-0010","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1158\/0008-5472.CAN-14-1456","article-title":"IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma","volume":"74","author":"Marie-Cardine","year":"2014","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.14626-BIB0011|bjd14626-cit-0011","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0012|bjd14626-cit-0012","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0190-9622(03)02484-8","article-title":"CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma","volume":"49","author":"Liu","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14626-BIB0013|bjd14626-cit-0013","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archdermatol.2009.280","article-title":"Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma","volume":"145","author":"Benner","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14626-BIB0014|bjd14626-cit-0014","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1001\/archdermatol.2009.74","article-title":"Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome","volume":"145","author":"Woo","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.14626-BIB0015|bjd14626-cit-0015","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/jid.2009.299","article-title":"Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP","volume":"130","author":"Braun","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0016|bjd14626-cit-0016","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jaad.2007.01.017","article-title":"Usefulness of flow cytometry in the diagnosis of mycosis fungoides","volume":"57","author":"Oshtory","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.14626-BIB0017|bjd14626-cit-0017","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/jid.2010.404","article-title":"Expression and function of the natural cytotoxicity receptor NKp46 on circulating malignant CD4+ T lymphocytes of S\u00e9zary syndrome patients","volume":"131","author":"Bensussan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0018|bjd14626-cit-0018","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2007-02-071993","article-title":"Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with S\u00e9zary syndrome","volume":"109","author":"Marie-Cardine","year":"2007","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0019|bjd14626-cit-0019","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1182\/blood-2012-10-460535","article-title":"Use of PLS3, Twist, CD158k\/KIR3DL2, and NKp46 gene expression combination for reliable S\u00e9zary syndrome diagnosis","volume":"121","author":"Michel","year":"2013","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0020|bjd14626-cit-0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/jid.2013.321","article-title":"NKp46-specific expression on skin-resident CD4+ lymphocytes in mycosis fungoides and S\u00e9zary syndrome","volume":"134","author":"Schneider","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0021|bjd14626-cit-0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/jid.2014.286","article-title":"KIR3DL2\/CpG ODN interaction mediates S\u00e9zary syndrome malignant T cell apoptosis","volume":"135","author":"Ghazi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.14626-BIB0022|bjd14626-cit-0022","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1182\/blood-2014-09-598995","article-title":"KIR3DL2 is a coinhibitory receptor on S\u00e9zary syndrome malignant T cells that promotes resistance to activation-induced cell death","volume":"124","author":"Thonnart","year":"2014","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0023|bjd14626-cit-0023","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"10.1111\/bjd.14626-BIB0024|bjd14626-cit-0024","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.clml.2013.03.008","article-title":"Complete response of relapsed systemic and cutaneous anaplastic large cell lymphoma using brentuximab vedotin: 2 case reports","volume":"13","author":"Broccoli","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1111\/bjd.14626-BIB0025|bjd14626-cit-0025","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1158\/1078-0432.CCR-12-1803","article-title":"U.S. Food and Drug Administration approval summary: brentuximab vedotin for the treatment of relapsed Hodgkin lymphoma or relapsed systemic anaplastic large-cell lymphoma","volume":"18","author":"Claro","year":"2012","journal-title":"Clin Cancer Res"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14626","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14626","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.14626\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:20:21Z","timestamp":1676384421000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/175\/2\/325\/6616657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,13]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14626","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7,13]]}}}